Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2024
DIAGAM from Ath, company number BE0451236575, closed financial year 2024 with a result of € 1.1 million after tax. For that financial year DIAGAM recorded a gross margin of € 3.3 million and equity of € 3.9 million. Compared with financial year 2023, the result moved from € 562,103 to € 1.1 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.
€ 3.9 million
▲ 26% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.1 million
▲ 88% vs 2023
Profit after tax over the fiscal year.
€ 838,064
▼ 7% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 100,000 paid out
9 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2024
21.2
▲ 2.9 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 1.5 million
▲ 18% vs 2023
€ 70,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 269,275
▲ 15% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 898,354
▲ 3% vs 2023
€ 507,954 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 1 million
▼ 20% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 586,196
▲ 93% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 1,788,419 | € 2,125,583 | € 2,396,174 | € 3,326,419 | ▲ 39% |
| Profit after taxes | € 425,129 | € 398,427 | € 562,103 | € 1,056,442 | ▲ 88% |
| Equity | € 2,620,334 | € 2,810,681 | € 3,064,696 | € 3,863,057 | ▲ 26% |
| Total debts | € 1,788,513 | € 1,843,698 | € 2,729,705 | € 2,745,261 | ▲ 1% |
| Cash | € 845,829 | € 1,028,542 | € 901,906 | € 838,064 | ▼ 7% |
| Land & buildings | € 454,922 | € 414,686 | € 525,687 | € 479,984 | ▼ 9% |
| Retained profit | € 2,438,211 | € 2,636,638 | € 2,898,733 | € 3,705,175 | ▲ 28% |
| Dividend | € 200,000 | € 200,000 | € 200,000 | € 100,000 | ▼ 50% |
| Bank debt | € 875,057 | € 671,188 | € 868,351 | € 898,354 | ▲ 3% |
| Balance sheet total | € 4,408,846 | € 4,654,379 | € 5,794,401 | € 6,608,319 | ▲ 14% |
| Employees (FTE) | - | 18.1 | 18.3 | 21.2 | ▲ 2.9 |
Key figures of DIAGAM, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to DIAGAM?
What happened at DIAGAM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- TARGERA SA stepped down as director. NBB
- Alice Ameryckx stepped down as director. NBB
- Katleen Paris stepped down as director. NBB
- New annual accounts for financial year 2024: profit of € 1.1 million (▲ 88% vs 2023). filed late Source: NBB ↗
- Alice Ameryckx became a director. NBB
- TARGERA SA became a director. NBB
- Katleen Paris became a director. NBB
- New establishment in Ath. KBO
In short
From € 425,129 profit in 2021 to € 1.1 million profit in 2024.
Paid € 1.1 million in corporate taxes since 2021.
Best year ever: 2024, with € 1.1 million profit.
On average € 156,900 of value added per employee in 2024.
A new publication or filing at DIAGAM? We notify you, reason included.
Follow DIAGAMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 33.2% of Global Food Development Company itself.
Directors
According to the 2024 annual accounts
Managing director · represented by Ameryckx GILBERT
since 2023 · until 2030
Katleen Paris
Managing director
since 2022 · until 2026
Alice Ameryckx
Managing director
since 2024 · until 2029
Establishments
Establishment units
Physical locations of this company
Rue du Parc Industriel(GHI) 40
7822 Ath
Rue du Parc Industriel(GHI) -
7822 Ath
Active since 7 December 2000
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
OVH Mail
Hosting
AS-HOSTINGER, CY
Domain
Domain
diagam.com
Registered
2001-10-14
Registrar
OVH, SAS
Expires
2026-10-14
Website info
Features
Security
Details
- Company number
- 0451.236.575
- VAT number
- BE 0451.236.575
- Registered office
- Rue du Parc Industriel(GHI) 40, 7822 Ath
- Names & denominations
- DIAGAM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 26 October 1993
- Peppol
- Active · Active since 27 Mar 2026
- Contact
- diagam.com
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Vervaardiging van andere chemische producten, neg
Overige technische testen en toetsen
Vervaardiging van overige chemische producten
Technische testen en analyses